ONCOLOGY AND HEMATOLOGY
Our goal is to offer innovative products and contribute to expanding patient access to the treatment of various malignant diseases through a dedicated Business Unit. We have highly specialized teams in Marketing & Sales, Market Access, Medical, Regulatory Affairs, R&D and Compliance. With the support of a recognized medical science advisory board, we identify the key innovations available to address the needs of patients and healthcare professionals.
We maintain close relationships with leading physicians, medical societies and institutions involved in the care and treatment of diseases in Oncology and Hematology.
We seek strategic alliances with partners of internationally recognized quality who share the same values as we do, with the health and well-being of patients as our ultimate goal.
Blanver operates directly in Brazil and has the capacity to serve all of Latin America through established collaborations with companies with experience in various licenses:
- Varifarma: With more than 25 years in the market and headquartered in Argentina, the company operates in the major countries of South America, including: Colombia, Ecuador, Chile and Peru.
- Stendhal: With more than 48 years of experience and headquartered in Mexico, the company operates in more than 14 countries in Latin America and the Caribbean.
Blanver, Varifarma and Stendhal together combine great experience to help companies succeed in the Latin American market with innovative products.
All companies share the same principles and values such as respect, ethics, focus on quality, result orientation, and social responsibility, as well as a commitment to the health and well-being of patients.
We are open to in-licensing opportunities for Brazil and Latin America. Become our partner.
Contact us for more information:
Rua Doutor Mario Augusto Pereira, 100, Galpão B, Jardim São Paulo, Taboão da Serra, São Paulo, CEP: 06767-330 • © Blanver 2020, Todos os direitos reservados